Literature DB >> 34928295

Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.

Michael Levy1, Morgan Recher2, Hervé Hubert2, Etienne Javouhey3, Olivier Fléchelles4, Stéphane Leteurtre2, François Angoulvant5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34928295      PMCID： PMC8689418          DOI： 10.1001/jama.2021.23262

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  29 in total

1.  Balancing risk and benefit of SARS-CoV-2 vaccines in children.

Authors:  Michael Levin; Elizabeth Whittaker
Journal:  Lancet Reg Health Eur       Date:  2022-05-29

2.  Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis.

Authors:  Christian Karagiannidis; Leif-Erik Sander; Marcus A Mall; Reinhard Busse
Journal:  Infection       Date:  2022-06-30       Impact factor: 7.455

Review 3.  Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children.

Authors:  Eric J Chow; Janet A Englund
Journal:  Infect Dis Clin North Am       Date:  2022-02-01       Impact factor: 5.905

4.  Case Report: MIS-C With Prominent Hepatic and Pancreatic Involvement in a Vaccinated Adolescent - A Critical Reasoning.

Authors:  Rita Consolini; Giorgio Costagliola; Erika Spada; Piero Colombatto; Alessandro Orsini; Alice Bonuccelli; Maurizia R Brunetto; Diego G Peroni
Journal:  Front Pediatr       Date:  2022-05-16       Impact factor: 3.569

5.  Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study.

Authors:  Kriangkrai Tawinprai; Taweegrit Siripongboonsitti; Thachanun Porntharukchareon; Preeda Vanichsetakul; Saraiorn Thonginnetra; Krongkwan Niemsorn; Pathariya Promsena; Manunya Tandhansakul; Naruporn Kasemlawan; Natthanan Ruangkijpaisal; Narin Banomyong; Nanthida Phattraprayoon; Teerapat Ungtrakul; Kasiruck Wittayasak; Nawarat Thonwirak; Kamonwan Soonklang; Gaidganok Sornsamdang; Nithi Mahanonda
Journal:  Vaccines (Basel)       Date:  2022-05-19

6.  Importance of understanding the reinfection risk of COVID-19 in children.

Authors:  Nigel W Crawford
Journal:  Lancet Child Adolesc Health       Date:  2022-03-28

7.  COVID-19 in children: From afterthought to unknown.

Authors:  Donato Amodio; Nicola Cotugno; Paolo Palma
Journal:  Cell Rep Med       Date:  2022-03-15

8.  Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.

Authors:  Anna R Yousaf; Margaret M Cortese; Allan W Taylor; Karen R Broder; Matthew E Oster; Joshua M Wong; Alice Y Guh; David W McCormick; Satoshi Kamidani; Elizabeth P Schlaudecker; Kathryn M Edwards; C Buddy Creech; Mary A Staat; Ermias D Belay; Paige Marquez; John R Su; Mark B Salzman; Deborah Thompson; Angela P Campbell
Journal:  Lancet Child Adolesc Health       Date:  2022-02-23

9.  Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.

Authors:  Laura D Zambrano; Margaret M Newhams; Samantha M Olson; Natasha B Halasa; Ashley M Price; Julie A Boom; Leila C Sahni; Satoshi Kamidani; Keiko M Tarquinio; Aline B Maddux; Sabrina M Heidemann; Samina S Bhumbra; Katherine E Bline; Ryan A Nofziger; Charlotte V Hobbs; Tamara T Bradford; Natalie Z Cvijanovich; Katherine Irby; Elizabeth H Mack; Melissa L Cullimore; Pia S Pannaraj; Michele Kong; Tracie C Walker; Shira J Gertz; Kelly N Michelson; Melissa A Cameron; Kathleen Chiotos; Mia Maamari; Jennifer E Schuster; Amber O Orzel; Manish M Patel; Angela P Campbell; Adrienne G Randolph
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-01-14       Impact factor: 17.586

Review 10.  Longitudinal Outcomes and Monitoring of Patients With Multisystem Inflammatory Syndrome in Children.

Authors:  Michael A Fremed; Kanwal M Farooqi
Journal:  Front Pediatr       Date:  2022-04-01       Impact factor: 3.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.